Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDU02
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,614
Award facts
- Contract value 100% obligated
- $69,614.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $69,614.33. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order serves as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
The supply of Dupixent, a specialty pharmaceutical used in the treatment of atopic dermatitis and other immune-mediated conditions, supports the Defense Health Agency and broader military healthcare operations. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability as a critical vendor for military pharmaceutical procurement, with a history of delivering diverse pharmaceutical products ranging from specialty medications to generic drugs across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling specialized medical supply requirements for the Department of Defense through the DLA's comprehensive pharmaceutical supply chain network.
Quick answers
Who was awarded contract SPE2DB26FDU02?
SPE2DB26FDU02 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDU02 worth?
The government has obligated $69,614 on SPE2DB26FDU02.
Is contract SPE2DB26FDU02 an order under another contract?
Yes. SPE2DB26FDU02 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDU02 competed?
The extent of competition for SPE2DB26FDU02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award